Clinitech Lab — 360° view

Clinitech Lab, a company in the Healthcare Service Provider industry, reported revenue of ₹5.49 crore and net profit of ₹0.24 crore for the September 2026 quarter.

Clinitech Lab (BSE: CTLLAB) closed at ₹32.05 on 20 Nov 2026, down 23.7% over the past year. Its market capitalisation is ₹7 crore and it trades at 15.2 times earnings.

Share price
₹32.05 (20 Nov 2026)
Market cap
₹7 Cr (20 Nov 2026)
P/E
15.25 (20 Nov 2026)
Revenue
₹5 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
7.27% (FY26)
ROE
4.65% (FY26)
Book value
₹41.6 (FY26)
Dividend yield
0.00% (FY26)
52-week high / low
₹47.15 / ₹28.55 (20 Nov 2026)
1-year return
-23.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Healthcare Service Provider
Symbol
BSE: CTLLAB

Incorporated in 1990, Clinitech Laboratory Ltd is in the business of providing pathology and related healthcare services.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.